Ліки, біль та харчування. Чи є зв’язок?
Аннотация
В обзорі йде мова про вплив їжі на сприйняття, появу чи полегшення болю.
Також висвітлюються деякі питання взаємодії їжі з ліками.
Ключевые слова
біль,
їжа,
ліки,
харчування
Литература
1. Anjaneyulu M, Chopra K. Quercetin, a bioflavonoid, attenuates thermal hyperalgesia in a mouse model of diabetic neuropathic pain // Prog Neuropsychopharmacol Biol Psychiatry, 2003, 27, 1001–5.
2. Bailey DG. Fruit juice inhibition of uptake transport, a new type of food-drug interaction // Br J Clin Pharmacol, 2010, 70, 645–55.
3. Bailey DG, Spence JD, Munoz C, Arnold JM. Interaction of citrus juices with felodipine and nifedipine // Lancet, 1991, 337, 268–9.
4. Bardocz S. The role of dietary polyamines // Eur J Clin Nutr, 1993, 47, 683–90.
5. Begon S, Pickering G, Eschalier A, Mazur A, Rayssiguier Y, Dubray C. Role of spinal NMDA receptors, protein kinase C and nitric oxide synthase in the hyperalgesia induced by magnesium deficiency in rats // Br J Pharmacol, 2001, 134, 1227–36.
6. Blasbalg TL, Hibbeln JR, Ramsden CE, Majchrzak SF, Rawlings RR. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century // Am J Clin Nutr, 2011, 93, 950–62.
7. Borzan J, Tall JM, Zhao C, Meyer RA, Raja SN. Effects of soy diet on inflammation-induced primary and secondary hyperalgesia in rat // Eur J Pain, 2010, 14, 792–8.
8. Chapkin RS, Kim W, Lupton JR, McMurray DN. Dietary docosahexaenoic and eicosapentaenoic acid, emerging mediators of inflammation // Prostaglandins Leukot Essent Fatty Acids, 2009, 81, 187–91.
9. Chizh BA, Headley PM, Tzschentke TM. NMDA receptor antagonists as analgesics, focus on the NR2B subtype // Trends Pharmacol Sci, 2001, 22, 636–42.
10. Cipolla BG, Havouis R, Moulinoux JP. Polyamine contents in current foods, a basis for polyamine reduced diet and a study of its long term observance and tolerance in prostate carcinoma patients // Amino Acids, 2007, 33, 203–12.
11. Cipolla BG, Havouis R, Moulinoux JP. Polyamine reduced diet (PRD) nutrition therapy in hormone refractory prostate cancer patients // Biomed Pharmacother, 2010, 64, 363–8.
12. Diet, nutrition and the prevention of chronic diseases // World Health Organ Tech Rep Ser, 2003, 916, i-viii, 1–149, backcover.
13. Dresser GK, Spence JD, Bailey DG. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition // Clin Pharmacokinet, 2000, 38, 41–57.
14. Egashira K, Sasaki H, Higuchi S, Ieiri I. Food-drug interaction of tacrolimus with pomelo, ginger, and turmeric juice in rats // Drug Metab Pharmacokinet, 2012, 27, 242–7.
15. Goldberg RJ, Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain // PAIN, 2007, 129, 210–23.
16. Lee FH, Raja SN. Complementary and alternative medicine in chronic pain // PAIN, 2011, 152, 28–30.
17. Lehto P, Kivisto KT, Neuvonen PJ. The effect of ferrous sulphate on the absorption of norfloxacin, ciprofloxacin and ofloxacin // Br J Clin Pharmacol, 1994, 37, 82–5.
18. Lotito SB, Frei B. Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans, cause, consequence, or epiphenomenon? // Free Radic Biol Med, 2006, 41, 1727–46.
19. Meyer BJ. Are we consuming enough long chain omega-3 polyunsaturated fatty acids for optimal health? // Prostaglandins Leukot Essent Fatty Acids, 2011, 85, 275–80.
20. Mijnhout GS, Kollen BJ, Alkhalaf A, Kleefstra N, Bilo HJ. Alpha lipoic acid for symptomatic peripheral neuropathy in patients with diabetes, a meta-analysis of randomized controlled trials // Int J Endocrinol, 2012, 2012, 456279.
21. Mony L, Kew JN, Gunthorpe MJ, Paoletti P. Allosteric modulators of NR2Bcontaining NMDA receptors, molecular mechanisms and therapeutic potential // Br J Pharmacol, 2009, 157, 1301–17.
22. Mosdol A, Erens B, Brunner EJ. Estimated prevalence and predictors of vitamin C deficiency within UK’s lowincome population // J Public Health (Oxf), 2008, 30, 456–60.
23. Okura T, Ozawa T, Ito Y, Kimura M, Kagawa Y, Yamada S. Enhancement by grapefruit juice of morphine antinociception // Biol Pharm Bull, 2008, 31, 2338–41.
24. Park CK, Xu ZZ, Liu T, Lu N, Serhan CN, Ji RR. Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice, distinct roles of resolvin D1, D2, and E1 // J Neurosci, 2011, 31, 18433–8.
25. Pickering G, Morel V, Simen E, Cardot JM, Moustafa F, Delage N, Picard P, Eschalier S, Boulliau S, Dubray C. Oral magnesium treatment in patients with neuropathic pain, a randomized clinical trial // Magnes Res, 2011, 24, 28–35.
26. Plumb MS, Aspden RM. High levels of fat and (n-6) fatty acids in cancellous bone in osteoarthritis // Lipids Health Dis, 2004, 3, 12.
27. Rivat C, Richebe P, Laboureyras E, Laulin JP, Havouis R, Noble F, Moulinoux JP, Simonnet G. Polyamine deficient diet to relieve pain hypersensitivity // PAIN, 2008, 137, 125–37.
28. Sawynok J. Caffeine and pain // PAIN, 2011, 152, 726–9.
29. Sawynok J, Reid AR. Caffeine inhibits antinociception by acetaminophen in the formalin test by inhibiting spinal adenosine A receptors // Eur J Pharmacol, 2012, 674, 248–54.
30. Shir Y, Campbell JN, Raja SN, Seltzer Z. The correlation between dietary soy phytoestrogens and neuropathic pain behavior in rats after partial denervation // Anesth Analg, 2002, 94, 421–6.
31. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases // J Am Coll Nutr, 2002, 21, 495–505.
32. Simopoulos AP. Importance of the ratio of omega-6/omega-3 essential fatty acids, evolutionary aspects // World Rev Nutr Diet, 2003, 92, 1–22.
33. Spencer JP, Vafeiadou K, Williams RJ, Vauzour D. Neuroinflammation, modulation by flavonoids and mechanisms of action // Mol Aspects Med, 2012, 33, 83–97.
34. Tall JM, Seeram NP, Zhao C, Nair MG, Meyer RA, Raja SN. Tart cherry anthocyanins suppress inflammationinduced pain behavior in rat // Behav Brain Res, 2004, 153, 181–8.
35. UNICEF. Progress for children, a report card on nutrition. Number 4. New York, UNICEF, 2006. ISBN 10, 92-806- 3988-9. Available from http, //www.unicef.org/publications/index_33685.html. [accessed 07.06.16].
36. U.S. Department of Agriculture, Agricultural Research Service. USDA national nutrient database for standard reference, Release 24, 2011. Nutrient Data Laboratory Home Page. Available at, http, //www.ars.usda.gov/ba/bhnrc/ndl. [accessed 03.06.12].
37. Valsecchi AE, Franchi S, Panerai AE, Rossi A, Sacerdote P, Colleoni M. The soy isoflavone genistein reverses oxidative and inflammatory state, neuropathic pain, neurotrophic and vasculature deficits in diabetes mouse model // Eur J Pharmacol, 2011, 650, 694–702.
38. Velandia B, Centor RM, McConnell V, Shah M. Scurvy is still present in developed countries // J Gen Intern Med, 2008, 23, 1281–4.
39. Woolf CJ, Salter MW. Neuronal plasticity, increasing the gain in pain // Science, 2000, 288, 1765–9.
40. Zhao C, Wacnik PW, Tall JM, Johns DC, Wilcox GL, Meyer RA, Raja SN. Analgesic effects of a soy-containing diet in three murine bone cancer pain models // J Pain, 2004, 5, 104–10.
2. Bailey DG. Fruit juice inhibition of uptake transport, a new type of food-drug interaction // Br J Clin Pharmacol, 2010, 70, 645–55.
3. Bailey DG, Spence JD, Munoz C, Arnold JM. Interaction of citrus juices with felodipine and nifedipine // Lancet, 1991, 337, 268–9.
4. Bardocz S. The role of dietary polyamines // Eur J Clin Nutr, 1993, 47, 683–90.
5. Begon S, Pickering G, Eschalier A, Mazur A, Rayssiguier Y, Dubray C. Role of spinal NMDA receptors, protein kinase C and nitric oxide synthase in the hyperalgesia induced by magnesium deficiency in rats // Br J Pharmacol, 2001, 134, 1227–36.
6. Blasbalg TL, Hibbeln JR, Ramsden CE, Majchrzak SF, Rawlings RR. Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century // Am J Clin Nutr, 2011, 93, 950–62.
7. Borzan J, Tall JM, Zhao C, Meyer RA, Raja SN. Effects of soy diet on inflammation-induced primary and secondary hyperalgesia in rat // Eur J Pain, 2010, 14, 792–8.
8. Chapkin RS, Kim W, Lupton JR, McMurray DN. Dietary docosahexaenoic and eicosapentaenoic acid, emerging mediators of inflammation // Prostaglandins Leukot Essent Fatty Acids, 2009, 81, 187–91.
9. Chizh BA, Headley PM, Tzschentke TM. NMDA receptor antagonists as analgesics, focus on the NR2B subtype // Trends Pharmacol Sci, 2001, 22, 636–42.
10. Cipolla BG, Havouis R, Moulinoux JP. Polyamine contents in current foods, a basis for polyamine reduced diet and a study of its long term observance and tolerance in prostate carcinoma patients // Amino Acids, 2007, 33, 203–12.
11. Cipolla BG, Havouis R, Moulinoux JP. Polyamine reduced diet (PRD) nutrition therapy in hormone refractory prostate cancer patients // Biomed Pharmacother, 2010, 64, 363–8.
12. Diet, nutrition and the prevention of chronic diseases // World Health Organ Tech Rep Ser, 2003, 916, i-viii, 1–149, backcover.
13. Dresser GK, Spence JD, Bailey DG. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition // Clin Pharmacokinet, 2000, 38, 41–57.
14. Egashira K, Sasaki H, Higuchi S, Ieiri I. Food-drug interaction of tacrolimus with pomelo, ginger, and turmeric juice in rats // Drug Metab Pharmacokinet, 2012, 27, 242–7.
15. Goldberg RJ, Katz J. A meta-analysis of the analgesic effects of omega-3 polyunsaturated fatty acid supplementation for inflammatory joint pain // PAIN, 2007, 129, 210–23.
16. Lee FH, Raja SN. Complementary and alternative medicine in chronic pain // PAIN, 2011, 152, 28–30.
17. Lehto P, Kivisto KT, Neuvonen PJ. The effect of ferrous sulphate on the absorption of norfloxacin, ciprofloxacin and ofloxacin // Br J Clin Pharmacol, 1994, 37, 82–5.
18. Lotito SB, Frei B. Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans, cause, consequence, or epiphenomenon? // Free Radic Biol Med, 2006, 41, 1727–46.
19. Meyer BJ. Are we consuming enough long chain omega-3 polyunsaturated fatty acids for optimal health? // Prostaglandins Leukot Essent Fatty Acids, 2011, 85, 275–80.
20. Mijnhout GS, Kollen BJ, Alkhalaf A, Kleefstra N, Bilo HJ. Alpha lipoic acid for symptomatic peripheral neuropathy in patients with diabetes, a meta-analysis of randomized controlled trials // Int J Endocrinol, 2012, 2012, 456279.
21. Mony L, Kew JN, Gunthorpe MJ, Paoletti P. Allosteric modulators of NR2Bcontaining NMDA receptors, molecular mechanisms and therapeutic potential // Br J Pharmacol, 2009, 157, 1301–17.
22. Mosdol A, Erens B, Brunner EJ. Estimated prevalence and predictors of vitamin C deficiency within UK’s lowincome population // J Public Health (Oxf), 2008, 30, 456–60.
23. Okura T, Ozawa T, Ito Y, Kimura M, Kagawa Y, Yamada S. Enhancement by grapefruit juice of morphine antinociception // Biol Pharm Bull, 2008, 31, 2338–41.
24. Park CK, Xu ZZ, Liu T, Lu N, Serhan CN, Ji RR. Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice, distinct roles of resolvin D1, D2, and E1 // J Neurosci, 2011, 31, 18433–8.
25. Pickering G, Morel V, Simen E, Cardot JM, Moustafa F, Delage N, Picard P, Eschalier S, Boulliau S, Dubray C. Oral magnesium treatment in patients with neuropathic pain, a randomized clinical trial // Magnes Res, 2011, 24, 28–35.
26. Plumb MS, Aspden RM. High levels of fat and (n-6) fatty acids in cancellous bone in osteoarthritis // Lipids Health Dis, 2004, 3, 12.
27. Rivat C, Richebe P, Laboureyras E, Laulin JP, Havouis R, Noble F, Moulinoux JP, Simonnet G. Polyamine deficient diet to relieve pain hypersensitivity // PAIN, 2008, 137, 125–37.
28. Sawynok J. Caffeine and pain // PAIN, 2011, 152, 726–9.
29. Sawynok J, Reid AR. Caffeine inhibits antinociception by acetaminophen in the formalin test by inhibiting spinal adenosine A receptors // Eur J Pharmacol, 2012, 674, 248–54.
30. Shir Y, Campbell JN, Raja SN, Seltzer Z. The correlation between dietary soy phytoestrogens and neuropathic pain behavior in rats after partial denervation // Anesth Analg, 2002, 94, 421–6.
31. Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases // J Am Coll Nutr, 2002, 21, 495–505.
32. Simopoulos AP. Importance of the ratio of omega-6/omega-3 essential fatty acids, evolutionary aspects // World Rev Nutr Diet, 2003, 92, 1–22.
33. Spencer JP, Vafeiadou K, Williams RJ, Vauzour D. Neuroinflammation, modulation by flavonoids and mechanisms of action // Mol Aspects Med, 2012, 33, 83–97.
34. Tall JM, Seeram NP, Zhao C, Nair MG, Meyer RA, Raja SN. Tart cherry anthocyanins suppress inflammationinduced pain behavior in rat // Behav Brain Res, 2004, 153, 181–8.
35. UNICEF. Progress for children, a report card on nutrition. Number 4. New York, UNICEF, 2006. ISBN 10, 92-806- 3988-9. Available from http, //www.unicef.org/publications/index_33685.html. [accessed 07.06.16].
36. U.S. Department of Agriculture, Agricultural Research Service. USDA national nutrient database for standard reference, Release 24, 2011. Nutrient Data Laboratory Home Page. Available at, http, //www.ars.usda.gov/ba/bhnrc/ndl. [accessed 03.06.12].
37. Valsecchi AE, Franchi S, Panerai AE, Rossi A, Sacerdote P, Colleoni M. The soy isoflavone genistein reverses oxidative and inflammatory state, neuropathic pain, neurotrophic and vasculature deficits in diabetes mouse model // Eur J Pharmacol, 2011, 650, 694–702.
38. Velandia B, Centor RM, McConnell V, Shah M. Scurvy is still present in developed countries // J Gen Intern Med, 2008, 23, 1281–4.
39. Woolf CJ, Salter MW. Neuronal plasticity, increasing the gain in pain // Science, 2000, 288, 1765–9.
40. Zhao C, Wacnik PW, Tall JM, Johns DC, Wilcox GL, Meyer RA, Raja SN. Analgesic effects of a soy-containing diet in three murine bone cancer pain models // J Pain, 2004, 5, 104–10.
Опубликована
янв 27, 2017
Как цитировать
BELL, R. F. et al.
Ліки, біль та харчування. Чи є зв’язок?.
Украинский журнал боли, [S.l.], v. 6, n. 2, p. 13-16, янв. 2017.
ISSN 2303-9736. Доступно на: <http://journal.pain.ua/ujp/article/view/45>. Дата получения: 26 апр. 2024
Раздел
Обзор
